Pseudoxanthoma Elasticum Clinical Trials

8 recruitingLast updated: May 13, 2026

There are 8 actively recruiting pseudoxanthoma elasticum clinical trials across 6 countries. Studies span Not Applicable, Phase 1, Phase 2, Phase 3. Top locations include Angers, France, Nice, France, Bonn, North Rhine-Westphalia, Germany. Updated daily from ClinicalTrials.gov.


Pseudoxanthoma Elasticum Trials at a Glance

8 actively recruiting trials for pseudoxanthoma elasticum are listed on ClinicalTrialsFinder across 6 cities in 6 countries. The largest study group is Not Applicable with 3 trials, with the heaviest enrollment activity in Angers, Nice, and Bonn. Lead sponsors running pseudoxanthoma elasticum studies include Centre Hospitalier Universitaire de Nice, Inozyme Pharma, and University Hospital, Angers.

Browse pseudoxanthoma elasticum trials by phase

Treatments under study

About Pseudoxanthoma Elasticum Clinical Trials

Looking for clinical trials for Pseudoxanthoma Elasticum? There are currently 8 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Pseudoxanthoma Elasticum trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Pseudoxanthoma Elasticum clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting
Not Applicable

Purinergic Compounds in Pseudoxanthoma Elasticum

Pseudoxanthoma Elasticum
Centre Hospitalier Universitaire de Nice45 enrolled2 locationsNCT07323082
Recruiting

Impact of Optimized Recruitment and Follow-up of Patients With Pseudoxanthoma Elasticum (PXE)

Pseudoxanthoma Elasticum
University Hospital, Angers650 enrolled1 locationNCT06636344
Recruiting
Phase 1

The ENERGY Study: Evaluation of Safety and Tolerability of INZ-701 in Infants With ENPP1 Deficiency or ABCC6 Deficiency

Pseudoxanthoma ElasticumEctonucleotide Pyrophosphatase/phosphodiesterase1 DeficiencyAutosomal Recessive Hypophosphatemic Rickets+2 more
Inozyme Pharma16 enrolled7 locationsNCT05734196
Recruiting
Not Applicable

CHOPXE - Analysis of Choriocapillaris Flow Deficits in Patients With Pseudoxanthoma Elasticum

Retinal DiseaseTomography Optical CoherencePseudoxanthoma Elasticum
University Hospital, Angers60 enrolled1 locationNCT07006649
Recruiting

Progression Assessment of PXE-associated Alterations

Pseudoxanthoma ElasticumAngioid StreaksPeau d'Orange+1 more
University Hospital, Bonn100 enrolled1 locationNCT07048106
Recruiting
Phase 2

ADAPT Study: Long-term Safety Study of INZ-701 in Patients With ENPP1 Deficiency and ABCC6 Deficiency

Arterial calcificationPseudoxanthoma ElasticumEctonucleotide Pyrophosphatase/phosphodiesterase1 Deficiency+2 more
Inozyme Pharma200 enrolled5 locationsNCT06462547
Recruiting
Not Applicable

PPI Supplementation to Fight ECtopIc Calcification in PXE

Pseudoxanthoma Elasticum
Centre Hospitalier Universitaire de Nice99 enrolled2 locationsNCT04868578
Recruiting
Phase 3

The Prevention of Systemic Ectopic Mineralization in Pseudoxanthoma Elasticum

Pseudoxanthoma Elasticum
UMC Utrecht76 enrolled1 locationNCT05832580